|
Kirsch, Kathrin; Kensinger, Margaret; Hanafusa, Hidesaburo et al. (2002) A p130Cas tyrosine phosphorylated substrate domain decoy disrupts v-crk signaling. BMC Cell Biol 3:18
|
|
Kirsch, K H; Georgescu, M M; Shishido, T et al. (2001) The adapter type protein CMS/CD2AP binds to the proto-oncogenic protein c-Cbl through a tyrosine phosphorylation-regulated Src homology 3 domain interaction. J Biol Chem 276:4957-63
|
|
Shishido, T; Akagi, T; Chalmers, A et al. (2001) Crk family adaptor proteins trans-activate c-Abl kinase. Genes Cells 6:431-40
|
|
Shishido, T; Akagi, T; Ouchi, T et al. (2000) The kinase-deficient Src acts as a suppressor of the Abl kinase for Cbl phosphorylation. Proc Natl Acad Sci U S A 97:6439-44
|
|
Akagi, T; Shishido, T; Murata, K et al. (2000) v-Crk activates the phosphoinositide 3-kinase/AKT pathway in transformation. Proc Natl Acad Sci U S A 97:7290-5
|
|
Wong, B R; Besser, D; Kim, N et al. (1999) TRANCE, a TNF family member, activates Akt/PKB through a signaling complex involving TRAF6 and c-Src. Mol Cell 4:1041-9
|
|
Georgescu, M M; Kirsch, K H; Shishido, T et al. (1999) Biological effects of c-Mer receptor tyrosine kinase in hematopoietic cells depend on the Grb2 binding site in the receptor and activation of NF-kappaB. Mol Cell Biol 19:1171-81
|
|
Besser, D; Bromberg, J F; Darnell Jr, J E et al. (1999) A single amino acid substitution in the v-Eyk intracellular domain results in activation of Stat3 and enhances cellular transformation. Mol Cell Biol 19:1401-9
|
|
Kirsch, K H; Georgescu, M M; Ishimaru, S et al. (1999) CMS: an adapter molecule involved in cytoskeletal rearrangements. Proc Natl Acad Sci U S A 96:6211-6
|
|
Georgescu, M M; Kirsch, K H; Akagi, T et al. (1999) The tumor-suppressor activity of PTEN is regulated by its carboxyl-terminal region. Proc Natl Acad Sci U S A 96:10182-7
|
Showing the most recent 10 out of 94 publications
